Tag: Anticoagulation

Full-dose or reduced-dose DOACs in high-risk VTE on extended therapy?

Presented By
Prof. Francis Couturaud, Brest University Hospital, France
Trial
Phase 3, RENOVE
Conference
ASH 2024
Type
Peer-reviewed article

29 January 2025 09:36

OCEANIC-AF: Asundexian inferior to apixaban for ischaemic stroke prevention in AF

Presented By
Dr Manesh Patel, Duke Clinical Research Institute, USA
Trial
Phase 3, OCEANIC-AF
Conference
ESC 2024
Type
Peer-reviewed article

7 November 2024 13:16

Anticoagulation or antiplatelet as secondary prevention for cancer-related strokes?

Presented By
Dr Moritz Kielkopf, University of Bern, Switzerland
Conference
EAN 2024
Type
News article

25 July 2024 10:26

Abelacimab substantially lowers bleeding risk compared with rivaroxaban 

Presented By
Dr Christian Ruff, Brigham and Women’s Hospital, USA
Trial
Phase 2, AZALEA-TIMI 71
Conference
AHA 2023
Type
Peer-reviewed article

29 January 2024 15:22

NOAH-AFNET 6: Does the duration of AHRE influence response to edoxaban?

Presented By
Dr Nina Becher, University of Hamburg, Germany
Trial
Phase 3, NOAH-AFNET 6
Conference
AHA 2023
Type
Peer-reviewed article

29 January 2024 15:13

ARTESIA: How useful is anticoagulation in subclinical AF? 

Presented By
Prof. Jeff Healey, McMaster University, Canada
Trial
Phase 4, ARTESIA
Conference
AHA 2023
Type
Peer-reviewed article

29 January 2024 15:08

Edoxaban versus warfarin in chronic thromboembolic pulmonary hypertension

Presented By
Dr Kazuya Hosokawa, Kyushu University, Japan
Trial
Phase 3, KABUKI
Conference
AHA 2023
Type
Peer-reviewed article

29 January 2024 14:09

Interview: Medicare’s first drug price negotiations: concerning?

Expert
Prof. Marc Bonaca, University of Colorado, USA

4 January 2024 15:06

Should we use anticoagulation in AHRE to prevent stroke?

Presented By
Prof. Paulus Kirchhof, University Heart & Vascular Center Hamburg, Germany
Trial
Phase 3, NOAH-AFNET 6
Conference
ESC 2023
Type
Peer-reviewed article

30 October 2023 16:05

Results of FRAIL-AF trial suggest increased bleeding risk with DOACs

Presented By
Dr Linda Joosten, University Medical Center Utrecht, the Netherlands
Trial
FRAIL-AF
Conference
ESC 2023

30 October 2023 16:04

The optimal duration of anticoagulation therapy in cancer patients with DVT

Presented By
Dr Yugo Yamashita, Kyoto University, Japan
Trial
ONCO DVT
Conference
ESC 2023
Type
Peer-reviewed article

30 October 2023 16:03

Anticoagulation in non-critically ill hospitalised COVID patients

Presented By
Prof. Valentín Fuster, Icahn School of Medicine at Mount Sinai, NY, USA
Trial
Phase 4, FREEDOM COVID Anticoagulation
Conference
ACC 2023
Type
Peer-reviewed article

7 June 2023 10:02

Neutral effect of P2Y12 inhibitors in non-critical COVID-19 hospitalisations

Presented By
Prof. Jeffrey Berger, New York University Langone, USA
Trial
ACTIV-4A
Conference
AHA 2021
Type
Peer-reviewed article

14 January 2022 16:30

Milvexian phase 2 data supports safety and efficacy for VTE prevention after total knee replacement

Presented By
Prof. Jeffrey Weitz, McMaster University, Canada
Trial
Phase 2, AXIOMATIC-TKR
Conference
AHA 2021
Type
Peer-reviewed article

14 January 2022 13:54

Head-to-head: Efficacy of dabigatran versus warfarin on cognitive impairment

Presented By
Prof. Bruno Caramelli, University of São Paulo, Brazil
Trial
Phase 4, GIRAF
Conference
AHA 2021
Type
Peer-reviewed article

14 January 2022 13:11

2021 ESC/EACTS Guidelines on Valvular Heart Disease

Presented By
Dr Victoria Delgado, Leiden University Medical Center, the Netherlands
Conference
ESC 2021
Type
Peer-reviewed article

26 October 2021 12:18

Favourable outcomes with transcatheter atrial appendage occlusion

Presented By
Dr Matthew Price, Scripps Clinic, USA
Trial
PROTECT AF, PREVAIL
Conference
ACC 2021
Type
Peer-reviewed article

9 July 2021 23:31

Apixaban outcomes similar to current standard of care following TAVR

Presented By
Prof. Jean-Philippe Collet, Sorbonne Université, France
Trial
ATLANTIS
Conference
ACC 2021
Type
Peer-reviewed article

9 July 2021 23:14

Therapeutic anticoagulation not superior to prophylactic anticoagulation in COVID-19

Presented By
Prof. Renato Lopes, Duke University Medical Center, USA
Trial
Coalition ACTION
Conference
ACC 2021
Type
Peer-reviewed article

9 July 2021 22:02

Anticoagulation with vitamin K antagonist is associated with risk of knee and hip replacement

Presented By
Dr Priyanka Ballal, Boston University Medical Center, USA
Conference
ACR 2020
Type
Peer-reviewed article

18 January 2021 10:48

2020 Atrial Fibrillation Guidelines

Presented By
Prof. Gerhard Hindricks, Heart Centre Leipzig, Germany
Conference
ESC 2020
Type
Peer-reviewed article

5 November 2020 14:05

POPular TAVI: Aspirin-only antiplatelet strategy?

Presented By
Dr Jorn Brouwer, St Antonius Hospital, the Netherlands
Trial
POPular TAVI trial
Conference
ESC 2020
Type
Peer-reviewed article

5 November 2020 13:28

Drug initiation strategy not associated with increased use of oral anticoagulants

Presented By
Prof. Sean Pokorney , Duke University, USA
Trial
IMPACT-AFib trial
Conference
ESC 2020
Type
Peer-reviewed article

5 November 2020 13:07

Risk factors for thromboembolism and bleeding in COVID-19: lessons from Wuhan

Presented By
Prof. Yutao Guo , Chinese PLA General Hospital, China
Conference
ESC 2020
Type
Peer-reviewed article

5 November 2020 12:27

Endovascular treatment in large vessel occlusion stroke patients treated with OAC

Presented By
Mr Clemens Küpper, Ludwig-Maximilians-University of Munich, Germany
Trial
German Stroke Registry-Endovascular Treatment
Conference
EAN 2020
Type
Peer-reviewed article

9 September 2020 16:13

Early edoxaban may be safe after cardioembolic stroke

Presented By
Dr Giovanni Frisullo, Fondazione Policlinico Universitario Agostino Gemelli IRCCS Roma, Italy
Trial
SATES
Conference
EAN 2020
Type
Peer-reviewed article

9 September 2020 16:09

Similar bleeding rates in patients with VTE and AF treated with DOACs

Presented By
Dr Farès Moustafa, CHU Clermont Ferrand, France
Conference
ISTH 2020
Type
Peer-reviewed article

8 September 2020 16:21

Therapeutic anticoagulation not associated with lower mortality rates in COVID-19 ICU patients

Presented By
Dr Hanny Al-Samkari, Massachusetts General Hospital, USA
Trial
Cohort study
Conference
ISTH 2020
Type
Peer-reviewed article

8 September 2020 15:15

Finding the sweet spot of anticoagulation in AF patients with ACS

Presented By
Prof. Renato D. Lopes, Duke University School of Medicine, USA
Trial
AUGUSTUS
Conference
ISTH 2020
Type
Peer-reviewed article

8 September 2020 14:59

Lower embryopathy risk with DOAC versus VKA during pregnancy

Presented By
Dr Jan Beyer-Westendorf, UNI-Klinikum Carl Gustav Carus Medizinische Klinik I, Germany
Conference
ISTH 2020
Type
Peer-reviewed article

8 September 2020 14:53

Edoxaban: alternative to warfarin after surgical aortic or mitral valve procedures?

Presented By
Dr G.R. Hong, Yonsei University College of Medicine, South Korea
Trial
ENAVLE
Conference
ACC 2020
Type
Peer-reviewed article

7 September 2020 23:15

Bleeding reduction post-TAVI with OAC alone vs OAC + clopidogrel

Presented By
Dr V. Nijenhuis, St. Antonius Hospital, the Netherlands
Trial
POPular-TAVI
Conference
ACC 2020
Type
Peer-reviewed article

7 September 2020 23:14

Apixaban offers new perspective for cancer patients in need of anticoagulation

Presented By
Prof. G. Agnelli, University of Perugia, Italy
Trial
Phase 3, CARAVAGGIO
Conference
ACC 2020
Type
Peer-reviewed article

7 September 2020 23:13

Rivaroxaban superior to enoxaparin in preventing VTE in non-major orthopaedic surgery

Presented By
Prof. N. Rosencher, Paris Center University Hospital, France
Trial
PRONOMOS
Conference
ACC 2020
Type
Peer-reviewed article

7 September 2020 23:07

Aspirin plus DOAC is not better than a DOAC alone

Presented By
Prof. Jordan Schaefer, University of Michigan, USA
Conference
ASH 2019
Type
Peer-reviewed article

5 March 2020 19:23

Full GALILEO results: Why did rivaroxaban fail after TAVR?

Presented By
Prof. George Dangas, Icahn School of Medicine at Mount Sinai, USA
Trial
GALILEO
Conference
AHA 2019

26 February 2020 20:28

Haematoma expansion and mortality in intracerebral haemorrhage after OAC

Conference
EAN 2019
Type
Peer-reviewed article

27 August 2019 12:54
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com